Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. (Q34753320)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. |
scientific article |
Statements
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype (English)
Bloomfield CD
Lawrence D
Byrd JC
Carroll A
Pettenati MJ
Tantravahi R
Patil SR
Davey FR
Berg DT
Schiffer CA
Arthur DC
1 September 1998